AQST FY 2024 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$431M

FY 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$58M+13.8% YoY

Gross Profit

$40M69.0% margin

Operating Income

-$31M-53.5% margin

Net Income

-$44M-76.7% margin

EPS (Diluted)

$-0.51

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$36M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$101M

Total Liabilities

$162M

Stockholders' Equity

-$60M

Cash & Equivalents

$72M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$58M	$51M	+13.8%
Gross Profit	$40M	$30M	+33.4%
Operating Income	-$31M	-$15M	-103.8%
Net Income	-$44M	-$8M	-460.8%